Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial
- 12 March 2010
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 375 (9717), 824-833
- https://doi.org/10.1016/s0140-6736(09)62038-9
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2New England Journal of Medicine, 2010
- Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral loadAIDS, 2009
- Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners StudyPLOS ONE, 2009
- Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South AfricaAIDS, 2009
- Herpes Simplex Virus (HSV)–Suppressive Therapy Decreases Plasma and Genital HIV‐1 Levels in HSV‐2/HIV‐1 Coinfected Women: A Randomized, Placebo‐Controlled, Cross‐Over TrialThe Journal of Infectious Diseases, 2008
- The Antiherpetic Drug Acyclovir Inhibits HIV Replication and Selects the V75I Reverse Transcriptase Multidrug Resistance MutationJournal of Biological Chemistry, 2008
- Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progressionAIDS, 2008
- Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trialAIDS, 2008
- Improved Performance of Enzyme-Linked Immunosorbent Assays and the Effect of Human Immunodeficiency Virus Coinfection on the Serologic Detection of Herpes Simplex Virus Type 2 in Rakai, UgandaClinical and Vaccine Immunology, 2008
- Regional Differences in Prevalence of HIV-1 Discordance in Africa and Enrollment of HIV-1 Discordant Couples into an HIV-1 Prevention TrialPLOS ONE, 2008